Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015

BACKGROUND: Disease modifying treatments (DMTs) are the main responsible for direct medical costs in multiple sclerosis (MS). The current investigation aims at evaluating possible associations between healthcare costs for treating relapsing remitting MS (RRMS) and disease evolution. METHODS: The pre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Moccia, Marcello, Palladino, Raffaele, Lanzillo, Roberta, Carotenuto, Antonio, Russo, Cinzia Valeria, Triassi, Maria, Brescia Morra, Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215923/
https://ncbi.nlm.nih.gov/pubmed/28056103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0169489
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados